← Back to Screener
Profusa, Inc. Common Stock (PFSA)
Price$0.34
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-112.45%
Price vs S&P 500 (4W)-41.86%
VGM Score5.93
Market Capitalization$1.65M
All Metrics
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-20.58
Price vs S&P 500 (YTD)-106.42%
EPS (TTM)$-183.27
10-Day Avg Trading Volume0.23M
EPS Excl Extra (TTM)$-183.27
EPS (Annual)$-110.00
ROI (Annual)17.25%
Cash / Share (Quarterly)$7.16
ROA (Last FY)-103.81%
EBITD / Share (TTM)$-14.61
Cash Flow / Share (Annual)$-16.54
P/B Ratio0.56x
ROA (TTM)-942.72%
EPS Incl Extra (Annual)$-110.00
Current Ratio (Annual)0.00x
Quick Ratio (Quarterly)0.17x
3-Month Avg Trading Volume3.57M
52-Week High$938.25
EPS Excl Extra (Annual)$-110.00
26-Week Price Return-96.52%
Quick Ratio (Annual)0.00x
13-Week Price Return-70.95%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)0.18x
Enterprise Value$19.71M
Cash / Share (Annual)$0.21
3-Month Return Std Dev323.59%
ROE (Last FY)20.06%
EPS Basic Excl Extra (Annual)$-110.00
Total Debt / Equity (Quarterly)0.54x
EPS Incl Extra (TTM)$-183.27
ROI (TTM)-16.62%
Revenue / Share (Annual)$0.00
Year-to-Date Return-95.49%
5-Day Price Return-5.79%
EPS Normalized (Annual)$-110.00
Month-to-Date Return-40.54%
EBITD / Share (Annual)$-17.06
EPS Basic Excl Extra (TTM)$-183.27
Price vs S&P 500 (13W)-80.70%
Beta0.44x
Revenue / Share (TTM)$0.00
ROE (TTM)-22.12%
52-Week Low$0.34
mGradeF
vgmGradeF
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PFSAProfusa, Inc. Common Stock | — | — | F | $0.34 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Profusa is a clinical-stage medical technology company developing implantable biosensors designed to integrate with the body and continuously transmit clinical-grade health data. The company's technology enables real-time monitoring of biomarkers for various diseases and conditions. Its lead product, the Lumee Oxygen Platform, is available in the European Union and measures tissue oxygen levels for both acute and long-term patient monitoring.